Exploring Novel Small Molecule & Gene Therapeutic Approaches for Tinnitus Indications for Improved Patient Care
Time: 12:00 pm
day: Conference Day 1
Details:
- Development of an operant behavioral mouse and gerbil model for Tinnitus drug discovery • GW-TT2 – Repurposing small molecule targeting Meniere’s disease-associated Tinnitus, delivered intra-nasally
- Development of a novel two-component gene therapy approach (GW-TT5) for the treatment of severe debilitating Tinnitus
- Incorporating biomarkers and improved diagnostics in preclinical and clinical designs for more predictable outcomes
